AU2004252395A1 - Methods for identifying agents, which regulate cytokines - Google Patents

Methods for identifying agents, which regulate cytokines Download PDF

Info

Publication number
AU2004252395A1
AU2004252395A1 AU2004252395A AU2004252395A AU2004252395A1 AU 2004252395 A1 AU2004252395 A1 AU 2004252395A1 AU 2004252395 A AU2004252395 A AU 2004252395A AU 2004252395 A AU2004252395 A AU 2004252395A AU 2004252395 A1 AU2004252395 A1 AU 2004252395A1
Authority
AU
Australia
Prior art keywords
receptor
nuclear factor
interaction
cell
cytokine class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004252395A
Other languages
English (en)
Inventor
Lotta Moreus
Vendela Parrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0301917A external-priority patent/SE0301917D0/xx
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2004252395A1 publication Critical patent/AU2004252395A1/en
Assigned to BIOVITRUM AB (PUBL) reassignment BIOVITRUM AB (PUBL) Alteration of Name(s) of Applicant(s) under S113 Assignors: BIOVITRUM AB
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2004252395A 2003-06-30 2004-06-28 Methods for identifying agents, which regulate cytokines Abandoned AU2004252395A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0301917-1 2003-06-30
SE0301917A SE0301917D0 (sv) 2003-06-30 2003-06-30 Methods for identifying active compounds
US49700303P 2003-08-20 2003-08-20
US60/497,003 2003-08-20
PCT/SE2004/001039 WO2005001478A1 (fr) 2003-06-30 2004-06-28 Procedes pour identifier des agents regulant les cytokines

Publications (1)

Publication Number Publication Date
AU2004252395A1 true AU2004252395A1 (en) 2005-01-06

Family

ID=33554620

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004252395A Abandoned AU2004252395A1 (en) 2003-06-30 2004-06-28 Methods for identifying agents, which regulate cytokines

Country Status (5)

Country Link
EP (1) EP1639371A1 (fr)
JP (1) JP2007527513A (fr)
AU (1) AU2004252395A1 (fr)
CA (1) CA2528281A1 (fr)
WO (1) WO2005001478A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006067063A2 (fr) * 2004-12-23 2006-06-29 Biovitrum Ab (Publ) Procedes de criblage
WO2016190321A1 (fr) * 2015-05-25 2016-12-01 シャープ株式会社 Gel d'électrophorèse, kit d'électrophorèse, dispositif d'électrophorèse, et procédé d'électrophorèse

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028492A1 (fr) * 1994-04-14 1995-10-26 Ligand Pharmaceuticals Incorporated Elements de regulation de l'adn sensibles aux cytokines
US5712094A (en) * 1995-03-27 1998-01-27 Ligand Pharmaceuticals, Inc. Methods for detecting modulators of cytokine action
AU6407696A (en) * 1995-07-07 1997-02-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of identifying inhibitors of the jak-stat signal transduction pathway
AUPQ005399A0 (en) * 1999-04-29 1999-05-27 Medvet Science Pty. Ltd. Agonists or antagonists for haemopoietic growth factors
SE9903953D0 (sv) * 1999-11-01 1999-11-01 Sahltech Ab New use of the jak-stat system
WO2001079555A2 (fr) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles des membres de la famille jak/stat dans l'induction de la tolerance

Also Published As

Publication number Publication date
WO2005001478A1 (fr) 2005-01-06
JP2007527513A (ja) 2007-09-27
EP1639371A1 (fr) 2006-03-29
CA2528281A1 (fr) 2005-01-06

Similar Documents

Publication Publication Date Title
Yi et al. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer
Zeng et al. ATF6 modulates SREBP2‐mediated lipogenesis
LeRoith et al. Molecular and cellular aspects of the insulin-like growth factor I receptor
EP3027225B1 (fr) Compositions et méthodes de modulation de thermogenèse à l'aide de facteur transformant de croissance alpha
US7744882B2 (en) Soluble ErbB3 methods of detection and antibodies
AU6174498A (en) Netrin receptors
Varco-Merth et al. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression
US20030096373A1 (en) Antibodies to a novel EGF-receptor related protein (ERRP)
KR101137019B1 (ko) 신규한 ｇｐｃｒ 단백질 및 이의 용도
US7285392B2 (en) Methods for identifying active compounds
AU2004252395A1 (en) Methods for identifying agents, which regulate cytokines
WO2009157919A1 (fr) Détection de erbb3 soluble, régulation et traitement du cancer
US7745398B2 (en) Soluble ErbB3 and treatment of cancer
US20070072186A1 (en) Methods and agents for screening for compounds capable of modulating her2 expression
CA2443676A1 (fr) Modulateur nouveau d'activite non genomique de recepteurs nucleaires (mnar) et applications connexes
KR102323971B1 (ko) 노화 억제 활성을 갖는 ｇｉｔ의 신규 용도
US20050014689A1 (en) Remedies for life style-related diseases or cibophobia and method of screening the same
EP2356216B1 (fr) Recepteur de type toll-3 du babouin papio cynocephalus
US9562227B2 (en) Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5
JP2006525244A (ja) 糖尿病の治療標的としてのインスリン誘導性遺伝子
Vaßen et al. Regulation of progesterone receptor activity in cell culture systems and cell-free transcription
WO2005071098A1 (fr) Methode de criblage de substance permettant d'ameliorer le metabolisme lipidique
JP2001510691A (ja) 新規のエストロゲン受容体βおよびそのイソ型タンパク質
Lin Regulation of sodium iodide symporter expression/function and tissue-targeted gene transfer of sodium iodide symporter
Miksicek et al. Splicing Variants of Estrogen Receptor in Breast Cancer

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application